78 evolution "https:" "https:" "https:" "Universidade do Minho CTAC" positions at UNIVERSITY OF SOUTHAMPTON
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
is on a fixed term basis till the end of February 2027. This position focuses on the development of innovative microfluidic-based sensors for continuous, in-situ chemical and biochemical analysis
-
on or before 2 August 2016. Where to apply Website https://www.timeshighereducation.com/unijobs/listing/409765/paediatric-asthma-a… Requirements Additional Information Work Location(s) Number of offers
-
mentoring and career development support from the line manager Jorn Lakowski and the other vision groups PI team. The post is available for a period of 2 years in the first instance. Interviews
-
. This position focuses on the development of innovative microfluidic-based sensors for continuous, in-situ chemical and biochemical analysis. About the Role: The successful candidate will join a dynamic research
-
their development of research and teaching within either the Human Development and Health school or Cancer Sciences school of the Faculty of Medicine, University of Southampton. In this post-doctoral role
-
Associate with a modelling background to lead development of the project’s multiphysics modelling framework. Key accountabilities / duties You will: Develop models describing acoustic emission generation and
-
(m.kalkowski@soton.ac.uk ) Where to apply Website https://www.timeshighereducation.com/unijobs/listing/409452/research-fellow-in-… Requirements Additional Information Work Location(s) Number of offers
-
and present your work at leading conferences, contributing to the visibility and impact of your field. Additionally, you will engage in continuous professional development to enhance your expertise and
-
to the visibility and impact of your field. Additionally, you will engage in continuous professional development to enhance your expertise and skills. Your role will also involve contributing to the university
-
at the University of Massachusetts, USA. We hope to move a compound forward toward Investigational New Drug (IND)-enabling studies and clinical development for severe asthma. Dr Haitchi’s group studies asthma and in